Integrating PLCM strategy in Pharmaceutical Emerging Market
Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 4
Abstract
All products and services must denote definite life cycles. The life cycle talks about the period from the product‘s first launch till it wind-up onto the market. Throughout this age noteworthy modifications are made in a way that the product is manifesting i.e. its mirror image with respect of sales. Ultimately increase of sustainable profit is the aim that every company aspires of the PLCM strategy. The understanding of a product‘s life cycle, can help a company to understand and realize when it is time to introduce and withdraw a product from a market, its position in the market compared to competitors, and the product‘s success or failure. This article details regarding Product Lifecycle Management in light of Pharmaceutical environment for the emerging markets (India, China, Russia, Brazil, and South Africa). Also an attempt has been made to compare PLCM of stated emerging countries with- highly regulated market (US).
Authors and Affiliations
Swagat Tripathy, Padala Narasimha Murthy, Bibhu Prasad Patra
Keywords
Related Articles
- EP ID EP426993
- DOI 10.22270/ijdra.v6i4.280
- Views 85
- Downloads 0
IMPORTANCE OF DEFICIENCY RESPONSE IN PHARMACEUTICAL ENVIRONMENT FOR DRUG APPROVAL
This illustrates examples of series deficiencies, that’s how really company faces problem due to deficiency. It’s to convey the message if drug product manufacturer can visualize earlier all aspect of risks and manifest...
EMERGING TRENDS IN ORAL BIOAVAILABILITY ENHANCEMENT
Oral route is one of the most accepted and convenient mode of drug administration, however low oral bioavailability of many drugs is a major concern which limits their oral administration. Optimum solubility and permeati...
NUTRACEUTICALS - A REGULATORY REVIEW
The Nutraceuticals are the emerging sector in the Pharma Industry. As people are more and more concerned about their health and diseases caused by the malnutrition, the growth of the Nutraceuticals worldwide are inevitab...
STATUS OF A T POLYMORPHISM IN EXON II OF KINASE INSERT DOMAIN GENE IN WOMEN WITH PREMATURE OVARIAN FAILURE
Ovarian failure is defined as cessation of ovarian function under the age of 40 and it is characterized by amenorrhea hypo estrogenism and elevated gonadotrophin serum levels leading to infertility. Ovarian failure affec...
HARMONIZATION & ADVANCEMENT IN PHARMACEUTICAL INDUSTRY
The urgent requirement to rationalize and harmonize regulation was impelled by instance of rising cost of Health care, Research and Development and need to meet the public requirement to approach for the safe and efficac...